Ht-Logo-gigapixel-icon
Wednesday, December 11, 2024
Canada’s Politics and Government News Source Since 1989
Wednesday, December 11, 2024 | Latest Paper

Dani Peters, Pamela Fralick, & Michael Hodin

Dani Peters is senior adviser to the Canadian Antimicrobial Innovation Coalition (CAIC). Pamela Fralick is president of Innovative Medicines Canada. Michael Hodin, PhD, is CEO of the Global Coalition on Aging.

Canada must renew leadership on antimicrobial resistance

Testing the susceptibility of Staphylococcus aureus to antibiotics by the Kirby-Bauer disk diffusion method. The federal government should work to pass regulatory reforms to help accelerate the approval and market launch of newly developed antibiotics. Ultimately, while learning from international best practices is important, Canada needs to develop a 'made-in Canada' approach well-suited to our unique health care systems, taking into account our federal, provincial and territorial components. Image courtesy of Wikimedia Commons
Testing the susceptibility of Staphylococcus aureus to antibiotics by the Kirby-Bauer disk diffusion method. The federal government should work to pass regulatory reforms to help accelerate the approval and market launch of newly developed antibiotics. Ultimately, while learning from international best practices is important, Canada needs to develop a 'made-in Canada' approach well-suited to our unique health care systems, taking into account our federal, provincial and territorial components. Image courtesy of Wikimedia Commons
Testing the susceptibility of Staphylococcus aureus to antibiotics by the Kirby-Bauer disk diffusion method. The federal government should work to pass regulatory reforms to help accelerate the approval and market launch of newly developed antibiotics. Ultimately, while learning from international best practices is important, Canada needs to develop a 'made-in Canada' approach well-suited to our unique health care systems, taking into account our federal, provincial and territorial components. Image courtesy of Wikimedia Commons
Testing the susceptibility of Staphylococcus aureus to antibiotics by the Kirby-Bauer disk diffusion method. The federal government should work to pass regulatory reforms to help accelerate the approval and market launch of newly developed antibiotics. Ultimately, while learning from international best practices is important, Canada needs to develop a 'made-in Canada' approach well-suited to our unique health care systems, taking into account our federal, provincial and territorial components. Image courtesy of Wikimedia Commons